financetom
Business
financetom
/
Business
/
-- US Judge Rules Argentina Must Turn Over 51% Stake in YPF, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- US Judge Rules Argentina Must Turn Over 51% Stake in YPF, Bloomberg Reports
Jun 30, 2025 10:20 AM

01:12 PM EDT, 06/30/2025 (MT Newswires) --

Price: 31.93, Change: -1.40, Percent Change: -4.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cornish Metals Starts Second Phase of Shaft Refurbishment at South Crofty Tin Project in U.K.
Cornish Metals Starts Second Phase of Shaft Refurbishment at South Crofty Tin Project in U.K.
Jul 11, 2024
09:42 AM EDT, 07/11/2024 (MT Newswires) -- Cornish Metals ( SBWFF ) , trading at 52 week lows, on Thursday said it has begun the second phase of shaft refurbishment at its South Crofty tin project in Cornwall, England. Vancouver-based Cornish also said it had received the initial payment for the sale of the Nickel King asset in the Northwest...
SentinelOne, Aon Collaborate to Mitigate Cyber Risk
SentinelOne, Aon Collaborate to Mitigate Cyber Risk
Jul 11, 2024
09:44 AM EDT, 07/11/2024 (MT Newswires) -- SentinelOne ( S ) and Aon (AON) are partnering to gather internal security data from SentinelOne ( S ) clients to more effectively manage and mitigate cyber risk, the companies said Thursday. SentinelOne ( S ) will provide threat detection and response technology through its Singularity Platform while Aon will assist clients using...
Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market
Pfizer Advances Once-Daily Weight-Loss Pill As It Catches Up To Tap The Lucrative Market
Jul 11, 2024
On Thursday, Pfizer Inc. ( PFE ) announced that, based on results from the ongoing Phase 1 pharmacokinetic study, it has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. Pfizer ( PFE ) plans to conduct dose optimization studies in the second half of 2024, evaluating multiple doses of the preferred modified...
Biodexa Says Data Show Longevity of Effect of Potential Precancerous Polyps Treatment -- Shares Soar
Biodexa Says Data Show Longevity of Effect of Potential Precancerous Polyps Treatment -- Shares Soar
Jul 11, 2024
09:45 AM EDT, 07/11/2024 (MT Newswires) -- Biodexa Pharmaceuticals ( BDRX ) said Thursday that 12-month data from a mid-stage clinical trial showed the longevity of effect of eRapa in the treatment of precancerous polyps in the gastrointestinal tract. The company said that based on the data, eRapa showed an overall 17% median decrease in overall polyp burden and non-progression...
Copyright 2023-2026 - www.financetom.com All Rights Reserved